>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Compass Minerals (CMP) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $15
    • CRISPR Therapeutics (CRSP) upgraded to Hold from Sell at TD Cowen; tgt $35
    • Mercury General (MCY) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $80
    • Upstart (UPST) upgraded to Buy from Neutral at B. Riley Securities; tgt raised to $105
    • Upstart (UPST) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $79
  • Downgrades:
    • Axcelis Tech (ACLS) downgraded to Mkt Perform from Outperform at William Blair
    • Fluence (FLNC) downgraded to Peer Perform from Outperform at Wolfe Research
    • Fluence (FLNC) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $6.50
    • Fluence (FLNC) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $7
    • Fluence (FLNC) downgraded to Neutral from Buy at UBS; tgt lowered to $8
    • On (ONON) downgraded to Neutral from Buy at Goldman; tgt $57
    • PPG Industries (PPG) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $115
    • STAAR Surgical (STAA) downgraded to Mkt Perform from Outperform at William Blair
    • STAAR Surgical (STAA) downgraded to Neutral from Buy at BTIG Research
    • STAAR Surgical (STAA) downgraded to Neutral from Outperform at Mizuho; tgt lowered to $17
    • Tempus AI (TEM) downgraded to Mkt Perform from Outperform at William Blair
    • Third Harmonic Bio (THRD) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $5
  • Others:
    • AstraZeneca (AZN) initiated with an Overweight at Morgan Stanley
    • Blaize Holdings (BZAI) initiated with a Buy at DA Davidson; tgt $10
    • CleanSpark (CLSK) initiated with a Buy at Needham; tgt $20
    • Exodus Movement (EXOD) initiated with a Buy at Compass Point; tgt $70
    • GlaxoSmithKline (GSK) initiated with an Equal-Weight at Morgan Stanley
    • Lucid Group (LCID) initiated with a Buy at The Benchmark Company; tgt $5
    • Novartis AG (NVS) initiated with an Underweight at Morgan Stanley
    • Novo Nordisk A/S (NVO) initiated with an Equal-Weight at Morgan Stanley
    • Ralph Lauren (RL) initiated with a Buy at Needham; tgt $310
    • Rapid Micro Biosystems (RPID) initiated with an Overweight at KeyBanc Capital Markets; tgt $8
    • Roche Hldg (RHHBY) initiated with an Equal-Weight at Morgan Stanley
    • Tesla (TSLA) initiated with a Buy at The Benchmark Company; tgt $475
    • V.F. Corp (VFC) initiated with a Buy at Needham; tgt $28

>>> Europe : Brokers Upgrades & Downgrades - 12th of February 2025 V2(+)

>>> Up
* Alpha Services Raised to Outperform at Mediobanca SpA
* BPER Banca Raised to Buy at Deutsche Bank; PT 7.60 euros
* Budimex Raised to Neutral at Citi; PT 551 zloty
* Carl Zeiss Meditec Raised to Hold at Stifel; PT 60 euros
* DiaSorin Raised to Buy at Stifel; PT 115 euros
* Grifols Raised to Overweight at Morgan Stanley; PT 12 euros
* Harbour Energy Raised to Neutral at Goldman; PT 245 pence
* Lufthansa Raised to Outperform at Bernstein; PT 8 euros (+)
* Marimekko Raised to Accumulate at Evli Bank; PT 13 euros
* NXP Semi Upgraded at Morgan Stanley on Aligning Tailwinds
* Piraeus Bank Raised to Outperform at Mediobanca SpA
* Ponsse Raised to Accumulate at Inderes; PT 24 euros
* Sartorius Raised to Overweight at Morgan Stanley; PT 340 euros
* Sartorius Stedim Raised to Overweight at Morgan Stanley
* Schott Pharma Raised to Buy at Stifel; PT 26.50 euros
* SGS PT Raised to 110 Swiss francs at Bank Vontobel (+)
* Teleste Raised to Accumulate at Inderes; PT 3.20 euros
* UPM-Kymmene Raised to Buy at Citi; PT 36 euros

>>> Down
* Alisa Pankki Oyj Cut to Reduce at Evli Bank; PT 18 euro cents (+)
* AstraZeneca Cut to Hold at Nordea
* Entain Cut to Neutral at BofA (+)
* Fortum Cut to Neutral at Oddo BHF; PT 15.50 euros (+)
* H&M Cut to Hold at Deutsche Bank; PT 160 kronor
* Hexagon Purus Cut to Hold at Pareto Securities; PT 2 kroner
* IAG Cut to Market Perform at Bernstein; PT 350 pence (+)
* L'Oreal Cut to Equal-Weight at Morgan Stanley; PT 379 euros
* Lanxess Cut to Neutral at Van Lanschot Kempen; PT 29 euros
* Logista Cut to Neutral at Grupo Santander; PT 33.20 euros
* Lonza Cut to Equal-Weight at Morgan Stanley; PT 625 Swiss francs
* Merck KGaA Cut to Equal-Weight at Morgan Stanley; PT 160 euros
* NNIT Cut to Sell at ABG; PT 70 kroner
* On Holding Cut to Neutral at Goldman; PT $57
* Orsted Cut to Neutral at BofA (+)
* Witted Megacorp Cut to Accumulate at Inderes; PT 1.80 euros

>>> Initiation
* Ashtead Technology Rated New Buy at Investec; PT 819 pence
* AstraZeneca Rated New Overweight at Morgan Stanley
* Covestro Rated New Market Perform at CICC; PT 62 euros
* GSK Reinstated Underweight at Morgan Stanley; PT 1,450 pence (+)
* GSK ADRs Reinstated Underweight at Morgan Stanley; PT $36 (+)
* HelloFresh Rated New Buy at M.M. Warburg; PT 15.40 euros (+)
* Novo Rated New Equal-Weight at Morgan Stanley; PT 700 kroner
* Novo ADRs Reinstated Equal-Weight at Morgan Stanley; PT $99 (+)
* Roche ADRs Reinstated Equal-Weight at Morgan Stanley; PT $42 (+)
* Roche Reinstated Equal-Weight at Morgan Stanley (+)
* Zegona Communications Rated New Outperform at Grupo Santander

>>> Call
* Heineken’s ‘Excellent’ Results Contain Little to Fault, RBC Says (+)
* L’Oreal Downgraded at Morgan Stanley Amid Decelerating Growth

FT Lex : Palantir’s exorbitant valuation mixes mystery and mayhem

Palantir’s exorbitant valuation mixes mystery and mayhem
US data analytics group could live up to the hype

If 2024 was the year Nvidia ate the world, 2025 belongs to Palantir. The defence-focused data-crunching company was the best-performing stock in the S&P 500 last year, overtaking the giant chipmaker after November’s US election. In the last week alone, its shares have risen by one-third, to give it a market capitalisation of nearly $260bn. The company’s mission: “making America more lethal”.

Explosive share price rises and bombastic rhetoric are easy fodder for meme stock-weary investors. Palantir certainly has many of the hallmarks. Chief executive Alex Karp describes his products as “powerful as fnck”. A valuation of 50 times next year’s forecast sales is twice the highest multiple ever afforded Tesla, Alphabet or Nvidia as listed companies.

Even so, Palantir could live up to the hype. Underneath the brimstone and vengeance, Palantir has worked out how to corral companies’ sprawling data troves to make them more efficient. To commercial customers, Palantir is something valuable if prosaic: a consultant that sells software, or what UBS analysts call a “McKinsey-meets-Databricks”.


Strip away the braggadocio, and it’s easier to have a sane conversation about Palantir’s worth. Analysts at Morningstar think it could one day capture 3 per cent of a total market worth $1.6tn, implying revenue of nearly $50bn. On a multiple of 10 times sales, in line with software giant Microsoft, Palantir should — eventually — be worth $500bn.

The question for investors is how long it takes to get there. Today, Palantir’s annual revenue is just $2.9bn. That’s the same size Salesforce, another software revolutionary, was in 2013. Marc Benioff’s company managed to sustain a growth rate above 20 per cent for almost a decade, something few companies have matched. 

Yet even at this rapid clip, Palantir would fall short. Indeed, using a 10 per cent cost of capital to discount future cash flows, it’s as if investors are saying Palantir can hit that revenue of $50bn in six years — a staggering 60 per cent annual growth rate.


One thing Palantir has now that Salesforce didn’t is AI. Companies like Microsoft, Amazon and OpenAI have sunk billions of dollars into models Palantir engineers can use to get creative. It doesn’t hurt either that Karp and co-founder Peter Thiel have established a revolving door of contacts between their company and western governments.

Those are powerful assets. Even armed with both of them, Karp needs to produce growth his predecessors couldn’t have imagined in order to justify that valuation. If he can keep up his knack for fuelling corporate greed and government fear, Palantir has a fighting chance.

>>> TradeGate Pre-Market Indications

DAX:
  • Sartorius (SRT3 TH) +2.6%
    • Sartorius Raised to Overweight at Morgan Stanley; PT 340 euros
  • Siemens Energy (ENR TH) +0.9%
    • Siemens Energy Sees Electricity Boom Driving Growth This Year
  • Rheinmetall (RHM TH) -0.5%
    • Watch Defense as Trump Preps Ukraine Peace Plan; MS Bullish
  • Merck KGaA (MRK TH) -1.6%
    • Merck KGaA Cut to Equal-Weight at Morgan Stanley; PT 160 euros
MDAX:
  • TeamViewer (TMV TH) +6%
    • TeamViewer Sees FY25 Pro Forma Revenue €778M to €797M
  • Schott Pharma AG & Co KGaA (1SXP TH) +2.9%
    • Schott Pharma Raised to Buy at Stifel; PT 26.50 euros
  • Lufthansa (LHA TH) +1.8%
    • Lufthansa Raised to Outperform at Bernstein; PT 8 euros
  • Carl Zeiss Meditec (AFX TH) -0.9%
    • Carl Zeiss Meditec 1Q Revenue Beats Estimates
  • Lanxess (LXS TH) -1%
    • Lanxess Cut to Neutral at Van Lanschot Kempen; PT 29 euros
SDAX:
  • Verbio SE (VBK TH) +9.4%
    • EQS-News: Significant EBITDA recovery in Q2 2024/25 compared to previous quarter
  • Borussia Dortmund (BVB TH) +4.5%
  • PVA TePla (TPE TH) +1.9%
  • Heidelberger Druck (HDD TH) +1.9%

>>> Stoxx 600 Pre-Market Indications

  • Heineken (HNK1 TH) +5.9%
    • Heineken FY Organic Beer Volume Beats Estimates
  • Heineken Holding (4H5 TH) +3.5%
  • Sartorius (SRT3 TH) +2.4%
    • Sartorius Raised to Overweight at Morgan Stanley; PT 340 euros
  • AB InBev (1NBA TH) +2%
  • Prosus (1TY TH) +1.9%
  • Lufthansa (LHA TH) +1.6%
  • UPM-Kymmene (RPL TH) +1.4%
    • UPM-Kymmene Raised to Buy at Citi; PT 36 euros
  • Grifols (OZTA TH) +1.4%
  • Carlsberg (CBGB TH) +1%
  • AstraZeneca (ZEG TH) +1%
    • AstraZeneca Cut to Hold at Nordea
  • Orsted (D2G TH) -1.2%
  • L’Oreal (LOR TH) -1.3%
    • L’Oreal Downgraded at Morgan Stanley Amid Decelerating Growth
  • Lanxess (LXS TH) -1.3%
    • Lanxess Cut to Neutral at Van Lanschot Kempen; PT 29 euros
  • Merck KGaA (MRK TH) -1.5%
    • Cut to equal-weight at Morgan Stanley: APA
  • Renault (RNL TH) -1.5%
    • Hon Hai Says It’s Open to Buying Renault’s Stake in Nissan (3)
  • Ahold Delhaize (AHOG TH) -3.4%
    • Ahold Delhaize 4Q Adjusted Operating Profit Beats Estimates
  • Voestalpine (VAS TH) -4.8%
    • Voestalpine Cuts FY Ebitda Forecast
  • Carl Zeiss Meditec (AFX TH) -5%
    • Carl Zeiss Meditec 1Q Revenue Beats Estimates

>>> What to look at today - 12th of February 2025

Bond yields climbed after Federal Reserve Chair Jerome Powell signaled patience before cutting interest rates further and as investors look ahead to the upcoming US CPI data. Hong Kong stocks rallied, powered by gains in Alibaba and BYD. Treasuries edged lower after falling across the curve on Tuesday, with money markets still fully pricing in one rate cut by the Fed this year. Australian and Japanese 10-year yields gained. The yen declined for a third consecutive day. US equity index futures were marginally lower while contracts in Europe rose.   Investors are cautious ahead of Wednesday’s CPI data even as Powell told Congress that the Fed doesn’t need to rush to adjust interest rates, indicating how the economy remained strong. The Fed had left its key policy rate unchanged in January, suggesting the stalled progress toward lower inflation warranted a patient approach. The technology theme continued to impact stocks in China and Hong Kong. Alibaba Group Holding Ltd. rose as much as 8.6%, the most since September 2024, after The Information reported that Apple Inc. is partnering with the company to bring AI features to products in China.  DeepSeek news has also helped lift the Hang Seng Index with UBS strategists including James Wang saying that the rally in Chinese stocks spurred by DeepSeek’s artificial intelligence app may be “less than halfway” done. Wall Street strategists from Morgan Stanley and JPMorgan Chase & Co. have also echoed this view.  BYD Co. surged to a new record, reflecting optimism that the Chinese electric vehicle leader will further challenge peers like Tesla Inc. through its smart-driving strategy.  The yen is on track for its longest losing streak in more than a month amid heightened concerns Japan may be included in President Donald Trump’s tariff plan. The currency was the worst performer among its Group-of-10 peers on Wednesday. The Japanese government asked Trump on Wednesday to exempt the nation’s companies from his fresh tariffs. In Asia, India’s rupee extended gains after rallying by the most in over two years Tuesday on suspected strong intervention by the central bank. Vietnam’s dong fell to a record low against the dollar on Tuesday. As traders await a key US inflation reading later today, prices have showed scant signs of downward momentum at the start of the year. Healthy job growth has also buoyed the economy, backing the Fed’s stance to hold the line on interest rates for now. Bureau of Labor Statistics figures due on Wednesday, shortly before the second half of Powell’s two-day testimony marathon, are forecast to show the consumer price index excluding food and energy rose 0.3% in January for the fifth time in the last six months. Money markets continued to fully price in just one quarter-point rate cut by the central bank this year, by September. In December, two 2025 cuts were priced in. A strong January jobs report released Friday prompted reassessment of the policy outlook, and January inflation data to be released Wednesday could do the same. In commodities, oil edged lower after an industry report indicated a large increase in US crude stockpiles. Gold edged down for a second day after a volatile trading in its previous session saw it surge to a fresh peak above $2,942. US After Hours UPST +23.5%, CFLT +13.4%, FRSH +10.2%, DASH +5.9% higher on earnings; BL -14.8%, TDC -14.5%, LYFT -10.2%, ALSN -9%, ZG -6.4% lower on earnings; SPIR -47.1% on going concern.

Nikkei +0.42% Hang Seng +1.92% CSI +0.29% Shanghai +0.32% Shenzen +0.73%

Eur$ 1.0357 CNH 7.3149 CNY 7.3087 JPY 153.65 GBP 1.2444 CHF 0.9132 RUB 96.5000 TRY 36.0415 WTI$72.99 -0.45% Gold 2,885 -0.45% BTC 95,825 -0.57% ETH 2,606 -0.60%

S&P -0.08% Nasdaq +0.04% EuroStoxx +0.24% FTSE +0.03% Dax +0.27% SMI +0.08%

Macro :
- European Commission Considering Temporary EU Gas Price Cap: FT
- Biggest US Grid Gets OK to Fast-Track Power Plants Amid AI Boom
- Multi-Manager Hedge Funds Pose Risks, BOE’s Bailey Says (1)
- Automakers Ask GOP for Gradual Phaseout of EV Tax Credits
- Japan Govt Seeks Exemption From US Steel Tariffs, Minister Says
- MSCI to Add United Airlines, Reddit to World Index

Keep an eye on :
- ABN NA : ABN Amro 4Q Operating Income Beats Estimates
- ACAST SS : Acast 4Q Gross Margin Beats Estimates
- AD NA : Ahold Delhaize 4Q Adjusted Operating Margin Matches Estimates
- AKRBP NO : Aker BP 4Q Revenue Beats Estimates
- AKTIA FH : Aktia Bank 4Q Adjusted EPS Beats Estimates
- BABA US : Alibaba’s Shares Soar After Investors Buy iPhone AI Hopes
- ALO FP : Alstom Gains After Signing €600m Contract With Deutsche Bahn
- AMBEA SS : Ambea 4Q Net Sales Beat Estimates
- ANORA FH : Anora Group Oyj 4Q Net Sales Meet Estimates
- ANIM IM : Banco BPM Raises Offer for Anima to EU7/Share
- BAMI IM : Banco BPM 4Q Net Income Beats Estimates
- BHP LN : BHP Names Ross McEwan as Chair to Succeed Ken MacKenzie
- BNP FP : BNP Paribas Names Philippe Maillard COO
- BPM IM : Banco BPM 4Q Net Income Beats Estimates
- CAN LN : Rubric Capital Management declared 5.01% in Canal + (50,925,541) - {NSN SRJ98XGFR4SG <GO>}
- AFX GY : Carl Zeiss Meditec 1Q Revenue Beats Estimates
- CARM FP : Carmila FY Ebitda Meets Estimates
- CA FP : Carrefour Submits Proposal to Make Atacadao Wholly-Owned Unit
- ROO LN : Deliveroo Readies for CEO to Step Down as Soon as This Year: Sky
- DB1 GY : Deutsche Boerse FY Ebitda Beats Estimates
- DB1 GY : Deutsche Boerse Is Said to Seek Pitches for IPO of ISS Stoxx
- DKSH SW : DKSH Sees 2025 Core EBIT to be Higher Than in 2024
- ELK NO : Elkem 4Q Operating Income Beats Estimates
- ENTRA NO : Entra 4Q Rental Income Meets Estimates
- GILD US : Gilead 2025 Adjusted EPS Forecast Beats Estimates
- HEIA NA : Heineken FY Organic Beer Volume Beats Estimates, Heineken Beer Shipments Rise on Strong Sales of Premium Beer
- JEN GY : Jenoptik Prelim FY Ebitda Margin About 19.9%
- KKR US : KKR Nears $14 Billion for Buyout Fund in Show of Momentum
- LIAB SS : Lindab FY Dividend per Share Beats Estimates
- MMT FP : M6 FY Ebita Meets Estimates
- MOWI NO : Mowi 4Q Ebit Beats Estimates, Mowi Boosts 2025 Harvest Forecast
- NWL IM : Newlat Food Holder Newlat Group Offers Shares
- SAVE SS : Nordnet Says Software Malfunction Was Root Cause of Problem
- ORRON SS : Orron Energy 4Q Revenue EU7.1M Vs. EU8.4M Y/y
- OVS IM : OVS Preliminary Sales for Fiscal 2024 Rose 6%
- OXY US : Buffett’s Berkshire Hathaway Boosts Stake in Occidental
- PIHLIS FH : Pihlajalinna 4Q EPS Beats Estimates
- BPSO IM : Popolare di Sondrio Rebuffs Offer From Rival BPER
- RAND NA : Randstad 4Q Organic Revenue Misses Estimates, Randstad 4Q North America Revenue Meets Estimates
- RNO FP : Hon Hai Says It’s Open to Buying Renault’s Stake in Nissan
- RESURS SS : Resurs Holding 4Q Operating Income SEK881M
- SCHP SW : Schindler FY Orders Meets Estimates
- SHEL LN : Shell’s Victory Over Emission Cuts Challenged at Top Dutch Court
- SIE GY : Siemens Unit Wins €2.8 Billion Deutsche Bahn Contract
- ENR GY : Siemens Energy 1Q Net Income EU252M Vs. EU1.58B Y/y
- 9984 JP : SoftBank 3Q Net Loss 369.17B Yen, Est. Loss 154.79B Yen, SoftBank Swings to a Loss Ahead of Big Stargate AI Bet
- SWTX US : SpringWorks Rises on FDA Approval of Rare Inoperable Tumor Drug
- STB NO : Storebrand 4Q Solvency II Beats Estimates, Storebrand 4Q Solvency II Beats Estimates
- TLGO SM : Poland’s PFR Is Ready to Pay at Least EU5 Per Talgo Share: DGP
- TMV GY : TeamViewer Sees FY25 Pro Forma Revenue €778M to €797M
- TEF SM : America Movil Signals Interest in Telefonica Argent.: Expansion
- TIT IM : Telecom Italia Gets Revised Bid for Sparkle Subsea Cable Unit
- TKA AV : Telekom Austria Sees 2025 Revenue +2% to +3%
- TOM2 NA : *TOM TOM CEO, CMO TO PURCHASE UP TO €10M IN COMPANY SHARES
- VOE AV : Voestalpine Cuts FY Ebitda Forecast, Voestalpine Cuts FY Ebitda Forecast, Sees Tariff Uncertainty (1)
- WAWI NO : Wallenius Wilhelmsen 4Q Pretax Profit Beats Estimates
- WITH FH : WithSecure 4Q Revenue Misses Estimates

FT : iPhone assembler Foxconn confirms interest in Renault’s Nissan stake

iPhone assembler Foxconn confirms interest in Renault’s Nissan stake
Taiwanese contract manufacturer says it would consider a deal only as part of co-operation on electric vehicles

Foxconn will consider acquiring Renault’s stake in Nissan if it is a condition for working with either carmaker on electric vehicles, the Taiwanese contract electronics manufacturer said on Wednesday.

“We did have talks about acquiring a stake in [Nissan],” Foxconn chair Young Liu told reporters on Wednesday in the company’s first confirmation of the talks. “If [taking a stake] is necessary for co-operation, we will consider it, but buying shares is not our main goal. Our main goal is co-operation.”

Liu’s comments clarify Foxconn’s rationale for negotiating an investment in Nissan after the breakdown of takeover talks between Honda and Nissan revived the possibility of a deal with the Taiwanese group.

Best known for its role as the main contract manufacturer of Apple’s iPhone, Foxconn is building a business designing and manufacturing EVs for other companies to sell under their own brands.

While it has signed up some EV start-ups as customers, contract orders from either Renault or Nissan would be its first partnership with a traditional carmaker outside its home market of Taiwan.

Liu said he expected to announce such a co-operation deal within one or two months, and Renault, Nissan and Honda were among carmakers in talks with Foxconn about contract orders.

Nissan did not immediately respond to a request for comment. Its shares had fallen 6.3 per cent by the early afternoon in Tokyo on the news and are down almost 13 per cent so far this year.

The company has come under fierce pressure due to competition from China and after failing to capture the hybrid boom in the US. As part of a turnaround plan, it intends to cut 9,000 jobs and a fifth of its production capacity.

The failed talks with Honda — which would have created the world’s fourth-largest automotive group — were precipitated by Foxconn’s interest in Nissan, according to people familiar with the matter.

Renault has been reducing its holding in Nissan ever since a drastic restructuring of their long-standing alliance in 2023. It has a 36 per cent stake in the Japanese company and wants to offload 18.7 per cent currently held in a French trust.

Jun Seki, chief strategy officer for Foxconn’s EV division and a former Nissan executive, was reported to have met Renault chief Luca De Meo in December for talks about acquiring shares held in the trust, triggering panic within Nissan and the frantic negotiations with rival Honda.

The Financial Times reported last week that Renault had reactivated talks with Foxconn. However, Nissan has the first right of refusal if the French group does decide to sell its shares.

Nissan is also conducting its own search for a strategic partner in the tech industry following the collapse of merger talks with Honda.